(JXN) Jackson Financial - Ratings and Ratios
Annuities, Life Insurance, Investment Contracts
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.61% |
| Yield on Cost 5y | 12.60% |
| Yield CAGR 5y | 13.30% |
| Payout Consistency | 100.0% |
| Payout Ratio | 15.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 34.6% |
| Value at Risk 5%th | 52.5% |
| Relative Tail Risk | -7.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.91 |
| Alpha | 10.66 |
| CAGR/Max DD | 1.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.500 |
| Beta | 1.355 |
| Beta Downside | 1.738 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.52% |
| Mean DD | 14.01% |
| Median DD | 12.91% |
Description: JXN Jackson Financial January 08, 2026
Jackson Financial Inc. (NYSE:JXN) operates a diversified annuity platform for U.S. retail investors, organized into three segments: Retail Annuities, Institutional Products, and Closed Life & Annuity Blocks. The Retail Annuities line sells variable, fixed-index, fixed, and payout annuities plus registered index-linked and lifetime income solutions. Institutional Products deliver guaranteed investment contracts, funding agreements tied to the Federal Home Loan Bank program, and medium-term funding-agreement-backed notes. The Closed Life segment offers whole life, universal life, variable universal life, term life policies, and group payout annuities, complemented by investment-management services. Distribution is broad, encompassing independent broker-dealers, wirehouses, regional brokers, banks, RIAs, third-party platforms, and insurance agents.
Recent filings show FY 2023 revenue of roughly $1.2 billion with a net income margin of ~5%, reflecting the low-margin nature of annuity underwriting. The business is highly interest-rate sensitive: rising yields improve the spread on fixed-index products but can suppress demand for fixed annuities as investors seek higher-yield alternatives. Demographic trends-particularly the aging of the Baby-Boom cohort-remain a tailwind for retirement-income solutions, while the broader diversified-financial-services sector is pressured by tightening capital requirements and heightened competition from fintech-enabled wealth platforms.
For a deeper, data-driven view of JXN’s valuation dynamics and scenario analysis, you might explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (576.0m TTM) > 0 and > 6% of Revenue (6% = 284.8m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -0.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 740.5% (prev 1312 %; Δ -571.2pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 5.66b > Net Income 576.0m (YES >=105%, WARN >=100%) |
| Net Debt (86.0m) to EBITDA (724.0m) ratio: 0.12 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (70.3m) change vs 12m ago -6.76% (target <= -2.0% for YES) |
| Gross Margin 40.93% (prev 4.17%; Δ 36.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.36% (prev 1.11%; Δ 0.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.08 (EBITDA TTM 724.0m / Interest Expense TTM 100.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.74
| (A) 0.10 = (Total Current Assets 50.65b - Total Current Liabilities 15.50b) / Total Assets 353.56b |
| (B) 0.02 = Retained Earnings (Balance) 7.74b / Total Assets 353.56b |
| (C) 0.00 = EBIT TTM 8.00m / Avg Total Assets 349.61b |
| (D) 0.01 = Book Value of Equity 5.13b / Total Liabilities 343.06b |
| Total Rating: 0.74 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.39
| 1. Piotroski 4.50pt |
| 2. FCF Yield 68.54% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.45 |
| 5. Debt/Ebitda 0.12 |
| 6. ROIC - WACC (= -7.13)% |
| 7. RoE 5.67% |
| 8. Rev. Trend -9.66% |
| 9. EPS Trend -16.72% |
What is the price of JXN shares?
Over the past week, the price has changed by +6.97%, over one month by +10.82%, over three months by +23.91% and over the past year by +42.34%.
Is JXN a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the JXN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 118.3 | 0.8% |
| Analysts Target Price | 118.3 | 0.8% |
| ValueRay Target Price | 168.9 | 44% |
JXN Fundamental Data Overview January 12, 2026
P/S = 1.6358
P/B = 0.8227
Beta = 1.452
Revenue TTM = 4.75b USD
EBIT TTM = 8.00m USD
EBITDA TTM = 724.0m USD
Long Term Debt = 4.65b USD (from longTermDebt, last quarter)
Short Term Debt = 8.00m USD (from shortTermDebt, last fiscal year)
Debt = 4.65b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 86.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.26b USD (8.17b + Debt 4.65b - CCE 4.56b)
Interest Coverage Ratio = 0.08 (Ebit TTM 8.00m / Interest Expense TTM 100.0m)
EV/FCF = 1.46x (Enterprise Value 8.26b / FCF TTM 5.66b)
FCF Yield = 68.54% (FCF TTM 5.66b / Enterprise Value 8.26b)
FCF Margin = 119.3% (FCF TTM 5.66b / Revenue TTM 4.75b)
Net Margin = 12.13% (Net Income TTM 576.0m / Revenue TTM 4.75b)
Gross Margin = 40.93% ((Revenue TTM 4.75b - Cost of Revenue TTM 2.80b) / Revenue TTM)
Gross Margin QoQ = 27.58% (prev none%)
Tobins Q-Ratio = 0.02 (Enterprise Value 8.26b / Total Assets 353.56b)
Interest Expense / Debt = 0.54% (Interest Expense 25.0m / Debt 4.65b)
Taxrate = -26.39% (negative due to tax credits) (-19.0m / 72.0m)
NOPAT = 10.1m (EBIT 8.00m * (1 - -26.39%)) [negative tax rate / tax credits]
Current Ratio = 3.27 (Total Current Assets 50.65b / Total Current Liabilities 15.50b)
Debt / Equity = 0.45 (Debt 4.65b / totalStockholderEquity, last quarter 10.23b)
Debt / EBITDA = 0.12 (Net Debt 86.0m / EBITDA 724.0m)
Debt / FCF = 0.02 (Net Debt 86.0m / FCF TTM 5.66b)
Total Stockholder Equity = 10.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.16% (Net Income 576.0m / Total Assets 353.56b)
RoE = 5.67% (Net Income TTM 576.0m / Total Stockholder Equity 10.16b)
RoCE = 0.05% (EBIT 8.00m / Capital Employed (Equity 10.16b + L.T.Debt 4.65b))
RoIC = 0.07% (NOPAT 10.1m / Invested Capital 14.14b)
WACC = 7.20% (E(8.17b)/V(12.82b) * Re(10.91%) + D(4.65b)/V(12.82b) * Rd(0.54%) * (1-Tc(-0.26)))
Discount Rate = 10.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.23%
[DCF Debug] Terminal Value 81.26% ; FCFF base≈5.76b ; Y1≈5.82b ; Y5≈6.30b
Fair Price DCF = 1927 (EV 131.04b - Net Debt 86.0m = Equity 130.95b / Shares 68.0m; r=7.20% [WACC]; 5y FCF grow 0.76% → 2.90% )
EPS Correlation: -16.72 | EPS CAGR: -46.31% | SUE: -4.0 | # QB: 0
Revenue Correlation: -9.66 | Revenue CAGR: -5.79% | SUE: -0.30 | # QB: 0
EPS next Quarter (2026-03-31): EPS=6.02 | Chg30d=+0.049 | Revisions Net=+3 | Analysts=2
EPS next Year (2026-12-31): EPS=24.69 | Chg30d=-0.141 | Revisions Net=+5 | Growth EPS=+12.5% | Growth Revenue=+5.7%
Additional Sources for JXN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle